Postnatal ontogeny of dopamine-β-hydroxylase (DBH)-like immunoreactive fibers in the rat cerebellar cortex has been studied by immunofluorescence on sagittal sections of the vermis. Except in the case of unusual thick highly fluorescent fibers noticed in the external granular layer during the first 2 weeks after birth, the arrival of DBH-containing fibers through the cerebellar cortex follows an inside-out gradient: at birth sparse fluorescent axons are observed in the album of the cerebellum. They invade the internal granular layer at postnatal day 2 (P2) and reach the Purkinje cell layer at P5. From P5 to P15, the density of fibers increases in this layer, which becomes the most innervated layer of the cerebellar cortex, as in the adult. When the external grains migrate, DBH-containing fibers extend progressively from depth to surface in the molecular layer and show an adult pattern at P30. The relationship between our results and other morphological and biochemical studies is discussed.

Keywords:
Dopamine-β-hydroxylase, Immunocytochemistry, Cerebellar cortex, Ontogenesis
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.